0635563 - BC 2026 RIV CH eng J - Článek v odborném periodiku
Majstorović, Jovana - Arakelyan, Anush - Trumbic, Z. - Kamiš, Jan - Adamek, M. - Roncevic, T. - Culic, V.C. - Kyslík, Jiří - Palus, Martin - Fiala, Ivan - Mladineo, Ivona
Cecropin anisaxin-2S has in vitro immunomodulatory, but not antiproliferative and antiviral properties.
Frontiers in Immunology. Roč. 16, MAY 5 2025 (2025), č. článku 1567505. ISSN 1664-3224. E-ISSN 1664-3224
Grant CEP: GA MŠMT(CZ) LX22NPO5103; GA ČR(CZ) GX19-28399X; GA MŠMT(CZ) LM2023050; GA MŠMT(CZ) EF18_046/0016045
GRANT EU: European Commission(XE) 101084204 - Cure4Aqua
Institucionální podpora: RVO:60077344
Klíčová slova: defense peptide ll-37 * red-blood-cells * antimicrobial peptide * interferon-gamma * immune-responses * dendritic cells * carp * differentiation * insights * receptor * anisaxin * antimicrobial peptide * red blood cells * white blood cells * immunomodulation
Obor OECD: Cell biology
Impakt faktor: 5.9, rok: 2024 ; AIS: 1.666, rok: 2024
Způsob publikování: Open access
https://doi.org/10.3389/fimmu.2025.1567505
Mladineo, Ivona
Trvalý odkaz: https://hdl.handle.net/11104/0370188